{
  "metadata": {
    "case_id": 34,
    "model": "Claude-4.5-Sonnet",
    "timestamp": "2025-11-29T15:53:28.172321",
    "total_alignments": 4,
    "target_section": "protocolSection",
    "ground_truth_path": "/{YOURPATH}/samples/CTG/protocolSection/1_100/34_NCT02137499.json",
    "prediction_path": "/{YOURPATH}/restructured_outputs_protocol/Claude-4.5-Sonnet/34_Claude-4.5-Sonnet.json",
    "shard_range": "1_100"
  },
  "alignments": [
    {
      "field_path": "protocolSection.armsInterventionsModule.armGroups",
      "algorithm": "hungarian",
      "ref_count": 4,
      "pred_count": 4,
      "similarity_matrix": [
        [
          0.78,
          0.42,
          0.3,
          0.4
        ],
        [
          0.4,
          0.93,
          0.7,
          0.72
        ],
        [
          0.5,
          0.8,
          0.9,
          0.8
        ],
        [
          0.6,
          0.5,
          0.82,
          0.9
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.78,
          "status": "matched",
          "ref_item": {
            "label": "Healthy subjects",
            "type": "ACTIVE_COMPARATOR",
            "description": "Healthy subjects, free from vascular disease",
            "interventionNames": [
              "Device: geko device"
            ]
          },
          "pred_item": {
            "label": "Healthy Subjects",
            "type": "EXPERIMENTAL",
            "description": "Healthy subjects without venous disease (n=10). Subjects wore bilateral leg NMES devices (geko™ T-1) for 4-6 hours per day, 5 days a week, for 6 weeks.",
            "interventionNames": [
              "DEVICE: Neuromuscular Electrical Stimulation (NMES) - geko™ T-1"
            ]
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 1,
          "score": 0.93,
          "status": "matched",
          "ref_item": {
            "label": "Superficial venous insufficiency",
            "type": "EXPERIMENTAL",
            "description": "Clinically symptomatic and ultrasound evidence of superficial venous insufficiency",
            "interventionNames": [
              "Device: geko device"
            ]
          },
          "pred_item": {
            "label": "Superficial Venous Insufficiency",
            "type": "EXPERIMENTAL",
            "description": "Patients with superficial venous insufficiency (n=10). Subjects wore bilateral leg NMES devices (geko™ T-1) for 4-6 hours per day, 5 days a week, for 6 weeks.",
            "interventionNames": [
              "DEVICE: Neuromuscular Electrical Stimulation (NMES) - geko™ T-1"
            ]
          }
        },
        {
          "ref_idx": 2,
          "pred_idx": 2,
          "score": 0.9,
          "status": "matched",
          "ref_item": {
            "label": "Deep venous insufficiency",
            "type": "EXPERIMENTAL",
            "description": "Clinically symptomatic and ultrasound evidence of deep venous insufficiency",
            "interventionNames": [
              "Device: geko device"
            ]
          },
          "pred_item": {
            "label": "Deep Venous Insufficiency",
            "type": "EXPERIMENTAL",
            "description": "Patients with deep venous insufficiency (n=10). Subjects wore bilateral leg NMES devices (geko™ T-1) for 4-6 hours per day, 5 days a week, for 6 weeks.",
            "interventionNames": [
              "DEVICE: Neuromuscular Electrical Stimulation (NMES) - geko™ T-1"
            ]
          }
        },
        {
          "ref_idx": 3,
          "pred_idx": 3,
          "score": 0.9,
          "status": "matched",
          "ref_item": {
            "label": "Deep venous obstruction",
            "type": "EXPERIMENTAL",
            "description": "Clinically symptomatic and ultrasound evidence of deep venous obstruction",
            "interventionNames": [
              "Device: geko device"
            ]
          },
          "pred_item": {
            "label": "Deep Venous Obstruction",
            "type": "EXPERIMENTAL",
            "description": "Patients with deep venous obstruction (n=10). Subjects wore bilateral leg NMES devices (geko™ T-1) for 4-6 hours per day, 5 days a week, for 6 weeks.",
            "interventionNames": [
              "DEVICE: Neuromuscular Electrical Stimulation (NMES) - geko™ T-1"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.armsInterventionsModule.interventions",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 1,
      "similarity_matrix": [
        [
          0.97
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.97,
          "status": "matched",
          "ref_item": {
            "type": "DEVICE",
            "name": "geko device",
            "description": "Small transcutaneous electrical stimulator. Manufactured in UK by Firstkind UK Ltd, and licensed for use in humans",
            "armGroupLabels": [
              "Deep venous insufficiency",
              "Deep venous obstruction",
              "Healthy subjects",
              "Superficial venous insufficiency"
            ]
          },
          "pred_item": {
            "type": "DEVICE",
            "name": "Neuromuscular Electrical Stimulation (NMES) - geko™ T-1",
            "description": "The geko™ T-1 device (Firstkind Ltd, UK) is a neuromuscular electrical stimulation device applied transcutaneously to the common peroneal nerve at the knee. It delivers intermittent electrical pulses (27mA, 1 Hz, pulse width 70-560μs) to cause contractions of the anterior and lateral compartments of the leg. Devices were fitted bilaterally and worn for 4-6 hours per day, 5 days a week, for 6 weeks. The minimum pulse width to achieve dorsiflexion was used and adjusted by the patient for comfort.",
            "armGroupLabels": [
              "Healthy Subjects",
              "Superficial Venous Insufficiency",
              "Deep Venous Insufficiency",
              "Deep Venous Obstruction"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.primaryOutcomes",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 3,
      "similarity_matrix": [
        [
          0.86,
          0.9,
          0.93
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 2,
          "score": 0.93,
          "status": "matched",
          "ref_item": {
            "measure": "Percentage Change of Haemodynamic Flow",
            "description": "Doppler ultrasound measurements of femoral venous blood flow. The volume flow rate in blood vessel can be calculated by multiplying the cross-sectional area of the blood vessel by the mean velocity of the blood within it.",
            "timeFrame": "baseline, 20 minutes"
          },
          "pred_item": {
            "measure": "Change in femoral vein volume flow (VF)",
            "description": "Percentage change in femoral vein volume flow measured by duplex ultrasound from baseline (device off) to device activation (device on) at 20 minutes, and at week 6",
            "timeFrame": "Baseline (week 0) at 20 minutes of device activation, and week 6"
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.secondaryOutcomes",
      "algorithm": "hungarian",
      "ref_count": 2,
      "pred_count": 8,
      "similarity_matrix": [
        [
          0.1,
          0.3,
          0.82,
          0.73,
          0.78,
          0.3,
          0.3,
          0.3
        ],
        [
          0.18,
          0.92,
          0.18,
          0.2,
          0.2,
          0.1,
          0.12,
          0.05
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 2,
          "score": 0.82,
          "status": "matched",
          "ref_item": {
            "measure": "Improvement in Venous Symptoms",
            "description": "Clinical symptoms will be measured using questionnaires (AVVQ, VCSS)",
            "timeFrame": "6 weeks"
          },
          "pred_item": {
            "measure": "Change in Venous Clinical Severity Score (VCSS)",
            "description": "Physician-reported quality of life assessment measuring venous clinical severity",
            "timeFrame": "Week 0, week 6, and week 8"
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 1,
          "score": 0.92,
          "status": "matched",
          "ref_item": {
            "measure": "Leg Volume",
            "description": "Measured using ankle and calf circumference, and multiplying using \"inverted cone\" method",
            "timeFrame": "6 weeks"
          },
          "pred_item": {
            "measure": "Change in unilateral leg volume",
            "description": "Change in leg volume calculated using truncated inverted cone model from ankle and maximal calf diameters measured bilaterally",
            "timeFrame": "Baseline (week 0) and week 6"
          }
        }
      ]
    }
  ]
}